These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 19967148)
1. Fibrin network structure and clot mechanical properties are altered by incorporation of erythrocytes. Gersh KC; Nagaswami C; Weisel JW Thromb Haemost; 2009 Dec; 102(6):1169-75. PubMed ID: 19967148 [TBL] [Abstract][Full Text] [Related]
2. Sensing adhesion forces between erythrocytes and γ' fibrinogen, modulating fibrin clot architecture and function. Guedes AF; Carvalho FA; Domingues MM; Macrae FL; McPherson HR; Santos NC; Ariёns RAS Nanomedicine; 2018 Apr; 14(3):909-918. PubMed ID: 29410160 [TBL] [Abstract][Full Text] [Related]
3. The spatial dynamics of fibrin clot dissolution catalyzed by erythrocyte-bound vs. free fibrinolytics. Gersh KC; Zaitsev S; Muzykantov V; Cines DB; Weisel JW J Thromb Haemost; 2010 May; 8(5):1066-74. PubMed ID: 20149071 [TBL] [Abstract][Full Text] [Related]
4. Whole blood clots are more resistant to lysis than plasma clots--greater efficacy of rivaroxaban. Varin R; Mirshahi S; Mirshahi P; Klein C; Jamshedov J; Chidiac J; Perzborn E; Mirshahi M; Soria C; Soria J Thromb Res; 2013 Mar; 131(3):e100-9. PubMed ID: 23313382 [TBL] [Abstract][Full Text] [Related]
5. Probing interactions of red blood cells and contracting fibrin platelet clots. Sun Y; Le H; Lam WA; Alexeev A Biophys J; 2023 Nov; 122(21):4123-4134. PubMed ID: 37598293 [TBL] [Abstract][Full Text] [Related]
6. Factor XIIIa-dependent retention of red blood cells in clots is mediated by fibrin α-chain crosslinking. Byrnes JR; Duval C; Wang Y; Hansen CE; Ahn B; Mooberry MJ; Clark MA; Johnsen JM; Lord ST; Lam WA; Meijers JC; Ni H; Ariëns RA; Wolberg AS Blood; 2015 Oct; 126(16):1940-8. PubMed ID: 26324704 [TBL] [Abstract][Full Text] [Related]
7. The association between human blood clot analogue computed tomography imaging, composition, contraction, and mechanical characteristics. Cruts JMH; Giezen JA; van Gaalen K; Beurskens R; Ridwan Y; Dijkshoorn ML; van Beusekom HMM; Boodt N; van der Lugt A; de Vries JJ; de Maat MPM; Gijsen FJH; Cahalane RME PLoS One; 2023; 18(11):e0293456. PubMed ID: 37956141 [TBL] [Abstract][Full Text] [Related]
8. Lytic resistance of fibrin containing red blood cells. Wohner N; Sótonyi P; Machovich R; Szabó L; Tenekedjiev K; Silva MM; Longstaff C; Kolev K Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2306-13. PubMed ID: 21737785 [TBL] [Abstract][Full Text] [Related]
9. Computational imaging analysis of fibrin matrices with the inclusion of erythrocytes from homozygous SS blood reveals agglomerated and amorphous structures. Averett RD; Norton DG; Fan NK; Platt MO J Thromb Thrombolysis; 2017 Jan; 43(1):43-51. PubMed ID: 27664114 [TBL] [Abstract][Full Text] [Related]
10. Impact of γ'γ' fibrinogen interaction with red blood cells on fibrin clots. Guedes AF; Carvalho FA; Domingues MM; Macrae FL; McPherson HR; Sabban A; Martins IC; Duval C; Santos NC; Ariëns RA Nanomedicine (Lond); 2018 Oct; 13(19):2491-2505. PubMed ID: 30311540 [TBL] [Abstract][Full Text] [Related]
11. A monoclonal antibody to the fibrinogen gamma-chain alters fibrin clot structure and its properties by producing short, thin fibers arranged in bundles. Scheiner T; Jirousková M; Nagaswami C; Coller BS; Weisel JW J Thromb Haemost; 2003 Dec; 1(12):2594-602. PubMed ID: 14675095 [TBL] [Abstract][Full Text] [Related]
12. Phase transitions during compression and decompression of clots from platelet-poor plasma, platelet-rich plasma and whole blood. Liang X; Chernysh I; Purohit PK; Weisel JW Acta Biomater; 2017 Sep; 60():275-290. PubMed ID: 28694237 [TBL] [Abstract][Full Text] [Related]
13. Simultaneous presence of hypercoagulation and increased clot lysis time due to IL-1β, IL-6 and IL-8. Bester J; Matshailwe C; Pretorius E Cytokine; 2018 Oct; 110():237-242. PubMed ID: 29396046 [TBL] [Abstract][Full Text] [Related]
15. Fibrin structure and concentration alter clot elastic modulus but do not alter platelet mediated force development. Carr ME; Carr SL Blood Coagul Fibrinolysis; 1995 Feb; 6(1):79-86. PubMed ID: 7795157 [TBL] [Abstract][Full Text] [Related]
16. Surfactant incorporation markedly alters mechanical properties of a fibrin clot. Günther A; Kalinowski M; Rosseau S; Seeger W Am J Respir Cell Mol Biol; 1995 Dec; 13(6):712-8. PubMed ID: 7576709 [TBL] [Abstract][Full Text] [Related]
17. Clot friction variation with fibrin content; implications for resistance to thrombectomy. Gunning GM; McArdle K; Mirza M; Duffy S; Gilvarry M; Brouwer PA J Neurointerv Surg; 2018 Jan; 10(1):34-38. PubMed ID: 28044009 [TBL] [Abstract][Full Text] [Related]